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ABSTRACT
One of the important role of Rho-dependent tran-
scription termination in bacteria is to prevent gene
expressions from the bacteriophage DNA. The tran-
scription anti-termination systems of the lambdoid
phages have been designed to overcome this Rho
action. The anti-terminator protein N has three inter-
acting regions, which interact with the mRNA, with
the NusA and with the RNA polymerase. Here, we
show that N uses all these interaction modules to
overcome the Rho action. N and Rho co-occupy
their overlapping binding sites on the nascent RNA
(the nutR/tR1 site), and this configuration slows
down the rate of ATP hydrolysis and the rate of
RNA release by Rho from the elongation complex.
N-RNA polymerase interaction is not too important
for this Rho inactivation process near/at the nutR
site. This interaction becomes essential when the
elongation complex moves away from the nutR
site. From the unusual NusA-dependence property
of a Rho mutant E134K, a suppressor of N, we
deduced that the N-NusA complex in the anti-
termination machinery reduces the efficiency of
Rho by removing NusA from the termination
pathway. We propose that NusA-remodelling is
also one of the mechanisms used by N to
overcome the termination signals.
INTRODUCTION
The factor-dependent transcription termination in bacteria
is carried out by a homo-hexameric RNA-dependent
ATPase, called Rho (1–3). In this termination process,
Rho at first recognizes 70–80 nt of unstructured C-rich
sequence known as rho utilization (rut) site on the
nascent RNA (4,5) through its N-terminal primary RNA
binding site (PBS; 6,7). This binding event guides the
3’-side of the RNA into the central hole of the hexamer,
which constitutes the secondary RNA binding site. This in
turn activates its ATP hydrolysis and translocase activity,
and the latter function is believed to be instrumental in
dislodging the elongation complex (EC; 8) inside a termin-
ation zone, which is usually located 60–90 nts downstream
of the rut site (9).
It is envisioned that the Rho-dependent termination in
bacteria has evolved not only to enforce a premature
termination of RNA synthesis in case of the failure of
ribosome-loading onto the mRNA but also to play a
major role in preventing the deleterious effects of tran-
scription of the foreign DNA injected by the bacterio-
phages (3). The anti-termination strategies of the
bacteriophages were primarily designed to combat
Rho-dependent termination process (10,11). In general,
these strategies involve the modifications of the EC by
phage-coded factors (protein or RNA) in such a way
that it can pass through the terminator signals without
getting dislodged from the template DNA.
N protein coded by the lambdoid phages is a
well-known anti-terminator that modifies the host RNA
polymerase (RNAP) during the transcription elongation
process together with the Nus factors (NusA, NusG,
NusB and NusE) of the host transcription machinery.
This modification helps the EC to express the middle
and late genes of lambdoid phages by suppressing many
Rho-dependent and -independent terminators present on
the phage DNA (10,11). N is a small RNA-binding
protein that interacts with a RNA-hairpin structure
(boxB) present in the N utilization (nut) site of the
nascent RNA through its N-terminal arginine rich motif
(ARM; Supplementary Figure S1A and B; 12). The
central domain of N interacts with NusA (13) and
recruits the latter to the spacer region of the nut site
(14), and subsequently this N-NusA-Nut RNA complex
works as a platform to recruit other Nus factors (15;
also see the cartoons in Figure 1). The C-terminal
regions of N binds to the RNAP (13) near the RNA exit
channel of the latter (16), which may involve penetration
*To whom correspondence should be addressed. Tel: +91 40 24749428; Fax: +91 40 24749343; Email: rsen@cdfd.org.in
Published online 29 September 2012 Nucleic Acids Research, 2012, Vol. 40, No. 22 11213–11228
doi:10.1093/nar/gks872
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloaded from https://academic.oup.com/nar/article-abstract/40/22/11213/1140964
by guest
on 28 May 2018
of part of this region of N into the active centre of the EC
(17). This configuration of N-Nus-EC complex makes the
transcription elongation process on the phage DNA
highly processive over a long distance (10).
The mechanism of N-mediated suppression of RNA
hairpin-dependent termination has been studied in detail
(16,18,19). However, the mechanism of anti-termination
of the Rho-dependent termination by N is not known.
In this report, we have provided genetic and biochemical
evidence for a multipronged strategy used by N to
overcome the Rho function. We showed that N (i) inacti-
vates Rho at the nutR site by forming a N-NusA-Rho
ternary complex, which renders slow rate of ATP hydroly-
sis of the former; (ii) exerts anti-termination most likely by
modifying the RNA exit channel of the EC, which is
operational even far away from the nut site; and finally
(iii) removes NusA from the Rho-dependent termination
path.
MATERIALS AND METHODS
Bacterial strains, phages and plasmids
Bacterial strains, plasmids and phages used in this study
are listed in Supplementary Table S4. All the in vivo anti-
termination assays were performed in different derivatives
of Escherichia coli rac strain MC4100. The strains
GJ5147 and RS445 used in b-galactosidase assays contain
single-copy Plac-H-19B nutR/tR1- lacZYA (GJ5147) or
Plac-lacZYA (RS445) reporter cassettes as RS45
lysogen. Strain RS1017 was constructed by moving Plac–
H-19B nutR/tR1- trpt’-lac ZYA reporter cassette by
RS45 mediated transduction from pRS992 into the
strain RS257. This construct has two terminators tR1
and trpt’ attached sequentially. Strain RS1018 and
RS1019 were also constructed by moving Plac-H-19B
nutR/tR1-tR’-lacZYA and Plac-nutR/ltR1–lacZYA,
respectively, in the same way into RS257. Temperature-
sensitive (ts) allele of rpoC [rpoCR120 (ts)] was moved to
RS445, RS734 and RS1017, resulting in strains RS940,
RS941and RS1029, respectively, by P1 transduction.
Plasmid pRS1092 was constructed by inserting trpt’
sequence at the SmaI site present after the nutR/tR1
sequence of pRS22 (pTL61T with pT7A1– H-19B
nutR-tR’-T1T2-lacZYA) to make the double terminator,
tR1-trpt’, construct. This trpt’ sequence was amplified
from pRS992 using oligos RS567/RS568. XL-red strain
(Stratagene) was used for random mutagenesis (20). The
mutagenesis procedure is described in the supplementary
methods.
Measurement of in vivo anti-termination
b-galactosidase activities from the lacZYA reporter is
fused to different terminator constructs were used to
measure the in vivo anti-termination. Ratios of b-gala-
ctosidase activities obtained in the presence and absence of
terminator cassettes gave the measure of anti-termination
(% RT). The strains RS734 and RS445 were transformed
with the plasmids having the mutants and wild-type (WT)
H-19B N genes to estimate the in vivo anti-termination
efficiency at the H-19B tR1 rho-dependent terminator
(Table 1). Similarly, the strains RS1017 and RS1018
were transformed with these plasmids to get the
bgalactosidase activities at H-19B tR1-trpt’ terminators
(Table 1) and at intrinsic terminator tR’ (Supplementary
Table S1), respectively. The strains RS1019 and RS445
were transformed with the plasmids having mutant and
WT  N genes to estimate the in vivo anti-termination
efficiency at tR1 rho-dependent terminator (Table 1).
The strains RS940, RS941 and RS1029 were used to get
the b-galactosidase activities in the presence of mutant
RNAP, carrying the ts alleles of rpoCR120 (rpoC). In
this case, strains were grown at 42C, to inactivate the
chromosomal copy of the WT rpoC gene (Table 1).
To estimate the in vivo termination efficiency of the sup-
pressor mutants of Rho at the H-19B tR1- trpt’ termin-
ator, the strains RS1017 and RS445 containing a plasmid
bearing H-19B N gene (pK8601) were transformed with
the suppressor and the WT Rho plasmids, and were sub-
sequently made rho in the chromosome by P1 transduc-
tion (Figure 6A). Ratios of the b-galactosidase activities
from the lysogens present in RS1017 and RS445 gave the
measure of the termination efficiency. Termination defects
of these suppressor mutants were also measured in the
absence of WT H-19B N (devoid of pK8601;
Supplementary Table S2).
All the measurements of b-galactosidase activities were
done in a microtiter plate using a Spectramax plus plate
reader following the published procedure (21,22).
In vitro transcription assays
In vitro Rho-dependent termination reactions were per-
formed in T buffer (25mM Tris–HCl (pH 8.0), 5mM
MgCl2, 50mM KCl, 1mM DTT and 0.1mg/ml of BSA)
at 32C. The reactions were initiated with 10 nM DNA,
40 nM WT RNAP, 175mM ApU, 5 mM each of GTP and
ATP and 2.5 mM CTP to make a 23-mer EC23. [a-
32P]CTP (3000Ci/mmol) was added to the reaction to
label the EC23. The complex was chased with 250 mM
NTPs in the presence of 10 mg/ml of rifampicin for
15min at 32C. Also, 50 nM WT Rho, 200 nM NusG,
300 nM NusA and 100 nM WT or mutant H-19B N
were added to the chase solution as indicated. The
reaction products were separated on 8% sequencing gels
and analysed by phosphorimager (Figures 2, 6 and 7).
Transcription reactions with T7A1-nutR–tR1-lacO or
T7A1-nutR-tR1-trpt’-lacO templates (Figure 3) were
done under the same conditions described earlier. In
both the cases, DNA was immobilized on the
streptavidin-coated magnetic beads, and 100 nM lac re-
pressor was added before chasing the 23-mer EC. For
RNA release assays, reactions were chased for 2
minutes, washed once, followed by the addition of Rho
in the presence of 1mM ATP. The reaction was incubated
at 32C for different time points, and half of the super-
natant was taken out for the ‘S’ lanes, and the rest was
phenol extracted and used for the ‘S+P’ lanes (Figures 3
and 6; Supplementary Figure S4). Preparations of N,
NusA and Rho proteins and the DNA templates are
described in the supplementary methods.
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ATPase assays
ATPase activity of the WT Rho protein was measured
from the release of inorganic phosphate (Pi) from ATP
after separating on the polyethyleneimine (PEI)-cellulose
TLC plates (Merck) with 0.75M KH2PO4 (pH 3.5) as the
mobile phase. In all the assays, the composition of the
reaction mixture was 25mM Tris–HCl (pH 8.0), 50mM
KCl and 5mMMgCl2, 1mMDTT and 0.1mg/ml of BSA.
Assays were performed on the nascent RNA emerging out
of the transcription EC. Stalled ECs were formed at the
lac operator site on the T7A1-nutR/tR1-lacO or T7A1-
nutR/tR1-trpt’-lacO templates in the same way as
described earlier. These complexes were incubated with
100 nM Rho in presence of 1mM NTPs and [g-32P]ATP
(3000Ci/mmol). Aliquots were removed and mixed with
1.5M formic acid at various time points to stop the
reaction. Release of Pi was analysed by exposing the
TLC sheets to a Phosphorimager screen for 5min and
subsequently by scanning using Typhoon 9200
(Amersham), and the intensities of ATP and Pi were
quantified by Image QuantTL software (Figure 4; Supple-
mentary Figure S2 and S3).
Amounts of ATP hydrolysed (in nanomoles) were
plotted against time using SIGMAPLOT software. The
data points for all the curves, except for+N, were fitted
to the equation of an exponential curve, y=a*[1-exp
(-*x)]. The data points obtained for ‘+N’ experiments
values were fitted to a sigmoidal equation; y=y0+a/
[1+exp {-(x x0)/}]. In these equations, ‘’ denotes the
rate and ‘a’ is the amplitude. The r2 values for each of the
fittings were 0.99. For rate calculations, only the initial
slopes were considered as later points in the curves
originated from multiple rounds of ATP hydrolysis by
Rho after dislodging the EC. The initial slopes of the
plots give ATPase activity of Rho in terms of nanomoles
of ATP hydrolysed per minute (8,21).
For the ATPase assays of E134K using poly(C), 50 nM
Rho was incubated with 1mM ATP, together with
[g-32P]ATP (3500Ci/mmol; BRIT, India) at 37C, and
ATP hydrolysis was initiated by the addition of 20 mM
poly(C). Products were analysed by the same way
as described earlier. The initial rates of the reaction
were determined by plotting the amount of hydrolysed
ATP versus time using linear regression method
(Figure 7D).
RNA footprinting
Footprinting assays were performed essentially in the
same way as described in (23). For RNase H footprinting
assays, four different DNA oligos, RS662, RS663, RS664
and RS665, antisense to H-19B nutR boxA, spacer, boxB
and the region immediately after boxB, respectively, were
used. Stalled EC was formed at the lacO site of the
template pT7A1-nutR-lacO-tR’ immobilized to the
magnetic beads, in the same way as described earlier, in
the presence of N, NusA and NusG. The EC was washed
to remove free NTPs and was then incubated with 50 nM
Rho in presence of 1mM AMPPNP. In all, 10 mM of each
of the anti-sense oligos were then added to the reactions
for 30 sec, following which one unit RNase H was added
and incubated for 1min at 32C. The reaction was stopped
by extracting with phenol, mixed with equal volume of
form amide loading dye and loaded onto an 8%
sequencing gel (Figure 5B).
For RNase T1 footprinting, stalled EC at the termin-
ator was formed in a similar way on the same template as
described for RNase H foot printing. Stalled EC was
washed extensively before footprinting, followed by incu-
bation for 5min with 50 nMWT Rho in presence of 1mM
AMPPNP. In all, 1U or 10U of T1 was added, and the
reaction was performed for 1min at 32C. Reactions were
stopped by phenol extraction. In both the footprinting
assays, the region of nut site was identified from the
anti-sense oligo-binding sites, migration of DNA
markers and the T1 sensitive single-stranded G residues
(Figure 5C).
Cross-linking of Rho and NusA
We have used a bi-functional cross-linker, LC-SPDP
(sulfosuccinimidyl 6-[30(2-pyridyldithio)-propionamido]
hexanoate (Pierce), which cross-links cysteine and amine.
We first labelled the surface-exposed primary amines (from
lys residues) of a no-cysteine derivative ofWT (C202A) and
Y80CRho (C202A). The mutant Y80C Rho could not
be made ‘zero’ cys to maintain the Y80C mutation. This
derivative of Rho has 28 lys residues against one cys (at the
position 80) per monomer; therefore, on SPDP labelling,
majority of the modifications will be in the lysines, and it
is likely that cysteins will not be labelled. The concentra-
tions of the cross-linker and Rho were 5 mM and 18 mM
(monomer concentration, which is also the concentration
of the cysteines), respectively. Concentration of the cross-
linker was kept less to get a sub-saturating labelling of Rho,
which ensured the absence of non-specific cross-linking
in the subsequent steps. The lowest concentration of
SPDP was determined by trials. Rho and SPDP were
mixed in phosphate buffer (100mM NaH2PO4, 150mM
NaCl, 1mM EDTA, pH 7.5), and incubation was
continued for 30min at 25C. Excess SPDP was removed
by passing the mixture through a protein-desalting column
(Pierce). In all, 100 nM of SPDP-derivatized Rho was then
added to the stalled EC, which was formed in a similar way
as in footprinting experiments using the same DNA
template, except that RNA was not radio-labelled,
instead P32-labelled WT NusA was used. WT NusA has
three cys residues (one is in KH1 domain and other two
are in AR2 domain). After formation of the stalled EC in
the presence of NusA and N, it was washed by phosphate
buffer, followed by incubation for 10min at 37C
with 100 nM of SPDP-labelled WT or Y80C Rho.
SPDP-Rho-N cross-linking was not attempted because
we observed very high level of non-specific adsorption of
N onto the streptavidin beads (Promega), which might had
led to spurious cross-linked products outside the EC.
Reactions were stopped by non-reducing SDS-sample dye
(-bME) and loaded onto a non-reducing 6–10% gradient
PAGE, and the products were analysed in a Fuji
phosphorimager (Figure 5E and F).
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RESULTS
Possible modes of N action
We hypothesized that N overcomes Rho-dependent ter-
mination by using any one or many of the following mech-
anisms (Figure 1).
(i) The nutR site (on the right operon) of the lambdoid
phages and the rut site of the tR1 Rho-dependent
terminator on the nascent RNA overlap with each
other (15,24). When the EC is proximal to this
site(s), nut-bound N-Nus factors-complex may
make the rut site inaccessible to Rho through a
competitive inhibition process (Figure 1A, left
panel). A functional competition for the nutR site
was proposed earlier (25,26). The superimposition
of the tR1 terminator on the nutR site provides an
unique opportunity to study the molecular basis of
the proposed functional competition between a ter-
minator and an anti-terminator. The nutL (on the
left operon) does not have an overlapping Rho-
dependent terminator, and hence we focussed only
on the nutR site.
(ii) It is possible that instead of competing out Rho
from the nutR site, N-NusA-Rho forms a ternary
complex by co-occupying the same site. In this
ternary complex, Rho may get fully inactivated or
its conversion into a translocase-competent form
becomes slow (Figure 1A, right panel). N only inter-
acts with the tetra-loop region of the boxB hairpin
(12), and this small footprint may not be enough to
occlude Rho from the same site.
(iii) These aforementioned two mechanisms involve
N-Nus factor complex mediated inhibition of the
Rho action specifically at the nutR/tR1 site. These
inhibitory mechanisms may not be effective when
the EC moves farther away from this site enforcing
a longer stretch of RNA to be looped out and
become accessible for Rho-binding (Figure 1B). To
prevent Rho-action in this case(s), it is required to
have a termination-resistant configuration of EC by
altering the RNA-exit channel formed by N-CTD-
RNAP interaction.
(iv) Rho and N uses the same factors, NusA and NusG,
for their functions (3,11). It is possible that removal
of NusA and NusG from Rho-dependent termin-
ation pathway by N makes Rho less efficient
(Figure 1C). Sequestration of NusG by N has
been speculated earlier (27,28). Functional removal
of NusA/NusG from the termination pathway may
involve N-mediated remodelling of these host
factors.
(v) N increases the elongation rate of the RNAP
(18,29), which enables the EC to overcome pausing
signals. Rate of transcription elongation is linked to
the efficiency of the Rho-dependent termination
through the ‘kinetic coupling’ of the RNAP elong-
ation and the Rho translocation (30). Increase in
elongation rate by N may uncouple this kinetic
coupling and affect the termination process.
We have tested all these hypotheses in the following
sections.
We first investigated the proposed competitive inhib-
ition between N and Rho for the accessibility of
nutR/tR1 site, a scenario that is described in Figure 1A
(hypothesis A).
Figure 1. Cartoons showing the possible hypotheses for overcoming Rho-dependent termination by N. (A) When the EC is near the nut/rut site, Rho
action can be inhibited by N either by a direct competition mechanism for the same site on the nascent RNA (left panel) or N and Rho can
co-occupy the same site, and this configuration delays the Rho activation step(s) (ring-closure and initiation of ATP hydrolysis; right panel).
(B) When the EC moves away from the nut/rut site, Rho can be excluded by N modification of the RNA exit channel through which Rho is
likely to approach the RNAP. (C) N functionally removes NusA and NusG from the Rho-dependent termination pathway by remodelling the
interactions.
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N-NutR interaction is sufficient to overcome Rho near the
nutR site
We have used a reporter construct where the nutR/tR1
sequence is fused to a lacZYA cassette (Plac-H-19B nutR/
tR1- lacZYA) present as a RS45 lysogen in a lac strain
of MC4100 (GJ5147; Supplementary Figure S1C, single
terminator construct; 16). This nutR/tR1 sequence has
the overlapping N (the nut site) and the Rho binding sites
(the rut site), and it is derived from a lambdoid phage
H-19B (31). In this construct, the lacZ expression occurs
only when H-19B N overcomes Rho-mediated termination
at the tR1, and, on MacKonkey lactose plates, the colonies
appear as red or pink. We transformed this GJ5147 strain
with the mutagenized library of H-19B N present on
the plasmids and screened for white/whitish colonies.
We isolated five unique H-19B N mutants defective for
anti-termination at tR1 terminator. All these mutations,
R3H, S11F, R15C, R15P and R18P, were located in the
nut-binding region of N (Supplementary Figure S1A).
R15C, R15P and R18P mutations are part of the ARM
(..12RSRRRER18..), which recognizes the nut site. Anti-ter-
mination assays (see ‘Materials and Methods’ section)
revealed that these mutations were severely defective on
this single terminator construct (Table 1). Even though
the mutagenesis process was random, we obtained point
mutations only in the RNA-binding domain of N.
Therefore, we hypothesized that the C-terminal RNAP-
binding domain of N (CTD) (Supplementary Figure
S1A) may not be functionally important for anti-termin-
ation on this construct. Dispensability of the c-terminal 14
amino acids of the N protein was observed earlier (32). To
test this, we made several deletions in the CTD of H-19BN.
Compared with the point mutants described earlier, the
deletions in the last 27 amino acids of H-19B N did not
show severe defect (1.5-fold compared with the WT) in
anti-termination. This defect was partial when the deletions
were in the region, 88–95 (Table 1). These results indicated
that the CTD of N may not be important for the anti-
termination activity on the single terminator construct.
The N CTD interacts with RNAP (13). If CTD–RNAP
interaction is not important for this construct, RNAP
mutants defective for N binding would be expected to
have little effect on anti-termination with this construct.
We have used two rpoC mutants, R270C and P251S/
P254L, which were defective for N-mediated anti-termin-
ation on hairpin-dependent terminators (16). Like N CTD
mutants, these were also not significantly defective for
anti-termination (Table 1, middle column). We also
made several deletions in the CTD (73–107 amino acids)
Table 1. In vivo antitermination at different Rho-dependent terminators by various N and RNAP alleles
Source of N N alleles RNAP alleles Plac-nutR/tR1-lacZYA
a Plac-nutR/tR1-trpt’-lacZYA
b
bgalactosidase activities (A.U.) bgalactosidase activities (A.U.)
+ter ter %RT +ter ter %RT
H-19B WT WT 998±25 2916±89 34.2 927±67 2916±89 31.8
R3H 335±17 4196±554 7.9
S11F 223±16 4404±565 5.1
R15C 136±12 3374±331 4.0
R15P 142±9 3844±335 3.7
R18P 157±4 3545±709 4.4 3.9±1.2 2201±150 0.18
78-127 293±45 3574±488 8.2
88-127 445±21 3611±590 12.3
96-127 489±11 2745±372 17.8 38±2 2745±372 1.4
101-127 730±14 2485±152 29.4 243±16 2485±153 9.8
106-127 670±21 3006±116 22.3 368±25 3006±116 12.2
111-127 648±17 2851±112 22.7 166±8 2851±112 5.8
121-127 769±11 2912±130 26.4 707±36 2912±130 24.3
c WT WT 1026±70 2699±196 38.0
73-107 192±13 2642±175 7.3
81-107 860±65 2450±292 35.1
91-107 940±64 2613±210 36.0
101-107 989±50 2488±139 39.8
H-19Bd WT WT 980±25 1969±82 49.7 834±31 2049±90 40.7
P251S, P254L 460±41 1327±45 34.7 303±24 1565±102 19.3
R270C 883±33 2934±342 30.1 636±35 2573±262 24.7
The above strains were transformed with the plasmids bearing different WT and mutant H-19B N (or  N) genes. The ratio of b-galactosidase values
in the presence (+ter) and absence (ter) of terminator gives the efficiency of terminator read-through (%RT). Two terminator-lacZYA fusions,
tR1-lacZYA and tR1-trpt’-lacZYA, were used. The Rho-dependent terminator, tR1 was derived from the nutR-cro region of either a lambdoid phage
H-19B (for H-19B N) or the phage (for  N). The errors are calculated from the average of 4 to 5 independent measurements.
aStrains RS734 (+ter) and RS445(ter)
bStrains RS1017(+ter) and RS445(ter)
cStrains RS1019 and RS445 with nutR/tR1 of -phage
dStrains RS941(+ter) and RS940(ter); eStrains RS1029 (+ter) and RS940 (ter); Experiments were performed at 42C to inactivate the temperature
sensitive (ts) allele of WT rpoC present in the chromosome and the WT and mutant rpoC were supplied from the plasmids. Anti-termination
efficiency increases at higher temperature. These two rpoC mutants did not support H-19B N mediated anti-termination and also the growths of 
and H-19B phages (16). These mutants are located near the RNA exit channel of the EC.
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of  N, and tested the same phenomenon using  nutR/
tR1construct (Table 1).  N, like H-19B N, also remained
fully active for anti-termination, despite the deletion of
major part of its RNAP-binding domain. As N-CTD
deletion and RNAP mutants affect the same step in
anti-termination, a double mutant would not have add-
itional effects.
Next we tested the in vitro anti-termination process
using a purified system by carrying out the reactions on
an H-19B nutR/tR1terminator template (Supplementary
Figure S1D, Figure 2A). On this template, WT N anti-
terminated very efficiently in the presence of NusA and
NusG, whereas the ‘ARM-mutant’, defective for N
binding, failed (arginines of ARM,..12RSRRRER18, are
changed to alanine; 16). But, the CTD N (101–127)
was able to show significant level of anti-termination
(Figure 2B). Similarly, the RNAP mutant, P251S/P254L,
also showed partial anti-termination activity on the same
template (Figure 2C).
Therefore, we concluded that both under in vivo and
in vitro conditions, the N-RNAP interaction is not essen-
tial to overcome the Rho-dependent termination near the
nut site.
RNAP modification by N is essential to overcome Rho
action away from the nutR site
Next, we explored the mode of inhibition of Rho func-
tion by N when the EC moves away from the nutR site
(Figure 1B; hypothesis C). We created an in vivo scenario
where the N-modified EC can become a target of Rho
when it is away from the nut site (as in Figure 1B), by
fusing one more Rho-dependent terminator, trpt’, (Sup-
plementary Figure S1C, Plac -nutR/tR1-trpt’-lacZYA)
downstream of the nutR site. Similar to the single termin-
ator construct, this one was also inserted into the chromo-
some as a lysogen (RS1017, Supplementary Table S4). In
this construct, Rho-entry site in the second terminator will
not face any interference from the N binding, as it is
devoid of nut site. We repeated the in vivo anti-termination
assays with WT and different N mutants on this construct.
On this template, point mutants in the ARM region
remained severely defective for the anti-termination as
before, but the CTD deletion mutants, which were
largely unaffected on the single terminator construct,
were now significantly defective (Table 1, right most
columns). 121–127 N was also not defective on this
template. Probably last seven amino acids of H-19B N
are functionally redundant (also see Supplementary
Table S1). Similarly, the RNAP mutants also showed
defect (Table 1, right most columns). However, this
defect was milder compared with the N CTD mutants.
We transcribed the double terminator template
(Supplementary Figure S1D, bottom panel; Figure 2D)
in vitro (Figure 2E) in the presence of different N proteins.
Rho terminated in the first terminator region, tR1, and the
WT N was able to overcome termination both at the tR1
and trpt’ terminators. The ARM-mutant N was com-
pletely defective. The CTD N showed transcription
read through of nutR/tR1, but failed do the same
through the downstream trpt’. Hence, N CTD-RNAP
interaction contributes significantly to overcome termin-
ation at the trpt’ terminator. The anti-termination defects
of CTD N and RNAP mutants strongly indicated the
requirement of the N-RNAP interactions for anti-termin-
ation away from the nut site, in contrast to the N-mediated
inhibition at or near the nut site. This essentiality of the
N-CTD-RNAP interaction is similar to that observed for
hairpin-dependent terminators (Supplementary Table S1;
16,17,19).
The aforementioned results suggest that the N-NTD-nut
site interaction offers a direct inhibition to Rho, whereas
N-CTD-RNAP interaction modifies the EC into a termin-
ation resistant form and prevents Rho action through the
anti-termination mechanism. Therefore, N uses both in-
hibition and anti-termination mechanisms to overcome
the Rho action.
N prevents Rho action from the stalled EC
A kinetic coupling between the transcription elongation
rate and the translocation rate of Rho determines the
efficiency of the Rho-dependent termination (30). We
tested whether N-mediated enhancement of transcription
elongation rate (18,29,33) plays an important role in
overcoming the action of Rho (hypothesis E). We
eliminated the effect of N on the elongation rate by
stalling the EC on two different immobilized templates
using lac repressor as a roadblock (RB complexes;
Figure 3A and B). We have earlier reported detailed
analyses of Rho-mediated RNA release from the ECs
stalled at different sequences and observed that Rho
releases RNA very efficiently from those complexes
(8, Supplementary Figure S2A). Lac-operator sequence
was fused either next to the nutR/tR1 terminator to stall
the EC near the nut site (Figure 3A) or after the tR1-trpt’
double terminator cassette to move the EC further away
from the nut site (Figure 3B). Rho+1 mMATP was added
to these stalled ECs formed in the presence of WT or dif-
ferent derivatives of N, and the RNA release in the super-
natant was measured over a period of time. The RNA
release from this RB by Rho was efficient, and the rate
of release in the absence of N was 1min1 (Figure 3E,
Supplementary Figure S2A), and this was comparable
with those observed earlier from other RBs (8). We
observed the following (Figure 3C–F). Presence of N
severely affected the Rho action from the stalled ECs by
delaying the RNA release from both the DNA templates.
However, Rho eventually overcame the N effect as was
evident from the sigmoidal RNA release curves (Figure 3E
and F). The ARM mutant N was defective on both the
templates, whereas the CTD N was defective only when
the EC was stalled further away from the nut site. These
results showed that (i) the N-nut interaction is more im-
portant for preventing Rho to act on the stalled ECs near
the nut site, whereas N-RNAP interaction is equally im-
portant for preventing the RNA release from the ECs
stalled further away from the nut site; and (ii) if sufficient
time is allowed, Rho is capable of overcoming the inhib-
ition/anti-termination function of N. This stabilization of
EC away from the nut site is similar to that observed with
the stalled EC at a terminator hairpin (19). Prevention of
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Figure 2. In vitro transcription termination assays on H-19B nutR/tR1and H-19B nutR/tR1- trpt’ terminator templates. (A) Cartoon of the H-19B
nutR/tR1 DNA template. Autoradiograms showing the single round in vitro transcription termination in the presence of different derivatives of N (B)
or RNAP (C). Termination regions are indicated by dotted lines next to the transcript bands. RO denotes the run-off product. The concentration of
Rho was 50 nM and that of N as indicated in (B) and 200 nM in (C). Amounts of WT RNAP holoenzyme and RNAP mutant were 25 nM and
50 nM, respectively. In all, 100 nM s70 was added to the RNAP mutant in (B). (D) Cartoon showing the design of the double terminator template.
(E) Autoradiogram showing the single round in vitro transcription termination in the presence of WT/mutant H-19B N on the immobilized template.
Lanes denoted as ‘S’ indicate half of the supernatant, and ‘P’ denotes the rest of the reaction mix. ‘RO’ denotes the run-off product. The concen-
trations of Rho and N were 50 nM and 200 nM, respectively. Released RNA will be in the ‘S’ lanes. Termination zones are indicated by dotted lines
and on the left side of the gel.
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Rho action by the N-modified stalled ECs also suggested
that N can prevent Rho action efficiently without
enhancing the elongation speed. However, we cannot
rule out that the contribution of the anti-pausing activity
of N (33) in overcoming the Rho action because it has
been shown that the change in RNAP elongation rate
does affect the efficiency of Rho action (30,34).
N reduces the rate of ATP hydrolysis of Rho at
the nut site
The observation that N reduces the rate of RNA release
by Rho (Figure 3E and F) and does not fully prevent Rho
from acting on the stalled ECs may be owing to the fol-
lowing reasons: (i) N delays the Rho loading onto the nut
site and also its access to the RNA exit channel of the
RNAP; and (ii) N slows down the initiation of ATP hy-
drolysis and the translocase activity of Rho. We tested the
effect of N bound to the nut site on the ATPase activity of
Rho. We have used the nascent RNA attached to the
stalled ECs (as described in Figure 3A and B), either
bound to N or in its absence, to activate the ATPase
function of Rho. The initial time points of the assay
actually measure the ATP hydrolysis activated by the
nascent RNA that is still attached to the stalled EC and
exhibits the effect of N bound to the EC. The later time
points reflect multiple rounds of ATP hydrolysis on the
released RNA from the ECs following the Rho-dependent
termination. WT N caused a significant delay in initiating
the ATP hydrolysis by WT Rho when the EC was near the
nut site (Figure 4A, compare the rates of ATP hydrolysis;
1.6 nmoles/min/mg Rho versus 0.22 nmoles/min/mg Rho),
but the effect of N was modest when the EC was placed
away from the nut site (Figure 4B; 1.7 nmoles/min/mg Rho
versus 1.1 nmoles/min/mg Rho). The CTD N also
exerted similar effect as the WT N near the nut site,
whereas the ARM-mutant N failed to elicit any effect
(Supplementary Figure S2B and C). These results
indicated that the effect of N on the ATPase activity of
Rho is confined near or at the nut site.
Further, we hypothesized that this inhibitory effect of N
can be overcome by increasing the rate of ATP hydrolysis
of Rho. We used a Rho mutant, P235H, with a higher rate
of ATP hydrolysis (Supplementary Figure S3A and B; 8).
Even in the presence of N, P235H Rho exhibited signifi-
cantly higher rate of ATP hydrolysis compared with the
WT when the EC was near the nut site (Figure 4C,
Figure 3. Effect of N on the Rho-mediated RNA release from the stalled elongation complexes at different distances from the nut site. Cartoon
showing the designs of stalled elongations complexes (RB) near the H-19B nutR/tR1 single terminator region (A) and after the H-19B nutR/tR1-trpt’
double terminator region (B) using lac repressor as a road-block. Distances from nutR-boxB to lacO sites in both the templates are indicated.
Autoradiograms showing the amount of RNA released by Rho, in the absence and presence of WT H-19B N at different time points from the RBs
made on the single terminator (C) and the double terminators templates (D). ‘RO’ denotes the RO products formed from the ECs that reached the
end of the template. Concentrations of Rho and H-19B N were 50 nM and 100 nM, respectively. These two templates were immobilized on
streptavidin-coated magnetic beads. The 0’ time points were obtained from incubating the RB in buffer having no Rho protein. ‘S’ denotes half
of the supernatant, and ‘P’ denotes the rest of the sample. Fractions of RNA release was estimated as, [2S]/([S]+[P]) and were plotted against time
(E, single terminator and F, double terminator) in the absence and presence of WT H19B N and its derivatives. Error bars are calculated from 2 to 3
independent measurements. The rates of RNA release indicated in the panels were calculated from the curve using the exponential rise equations. In
case of +WT N curves, the rates were obtained from the initial slope.
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3.2 nmoles/min/mg Rho versus 1.8 nmoles/min/mg Rho;
2-fold). This resulted into a reduction of the N-induced
delay of the initiation of ATP hydrolysis. This delay was
fully eliminated when the EC was away from the nut site
(Figure 4D). Hence, we concluded that the inhibitory
mechanism of N at or near the nut/rut site involves
slowing down of the initiation of the ATP hydrolysis
by Rho.
Co-occupancy of Rho with the N-NusA/G complex at the
nut site (hypothesis B)
The reduction of the rate of ATPase activity of Rho by N
favours an inhibition model wherein N inactivates Rho at
or near the nut site, which is likely to be manifested as a
functional competition between N and Rho for the same
site on the RNA as proposed earlier (26). To achieve the
inactivation of Rho, it is possible that the N-NusA/G
complex will co-occupy the nutR/rut site with Rho. We
tested for the co-occupancy by footprinting the nutR/tR1
site of the nascent RNA of the stalled EC in presence of
different factors and also by cross-linking of NusA and
Rho both bound to this site.
We stalled the EC in the presence and absence of N by
lac repressor bound at a lacO site located 90 nt away
from the boxB hairpin of the nutR/rut site (Figure 5A,
Supplementary Figure S4A). Rho+AMPPNP (a non-
hydrolyzable ATP analogue for maintaining the
hexameric state) was added to this stalled EC. We have
earlier observed that AMPPNP-bound Rho interacts spe-
cifically with the spacer region of the nut/rut site with a
small footprint (22 nt), which most likely reflects the
initial RNA-loading step of Rho (23). This footprint is
significantly smaller than that observed during the trans-
location of Rho (>60 nt) in the presence of ATP hydroly-
sis. On this stalled EC, N remained functionally active
(Supplementary Figure S4B and C).
Footprinting experiments were performed by RNase H
and RNase T1-mediated cleavages of the nascent RNA
attached to the EC (as in Figure 5A). RNase H cleaves
at the RNA:DNA hybrids. We have used DNA oligo-
nucleotides anti-sense to spacer and boxB regions of the
nutR/rut site (see next to the gel pictures of Figures 5B and
C; Figure 5D). Binding of N, NusA/G and Rho to the
nutR/rut site will prevent the oligos from binding, which
will lead to less sensitivity towards RNase H. RNase
H/oligo combination produced cleavages only at
RNA:DNA hybrids (Figure 5B lanes without any factors
and Supplementary Figure S5). RNase T1 cleaves at the
Figure 4. Effect of N on the rate of ATP hydrolysis by Rho. Amounts of [g-32P]ATP hydrolysed by Rho in nanomoles are plotted against time both
in the absence and presence of WT H-19B N. These assays were performed on the nascent RNA coming out of the stalled ECs formed (A) on single
terminator (as in Figure 3A) and (B) on double terminator (as in Figure 3B) templates.100 nM each of Rho and H-19B N were used. In all, 300 nM
NusA and 200 nM NusG were also present in these assays. The initial rates of ATP hydrolysis are indicated by dashed lines. Same experiments
performed on ECs stalled at the single terminator (C) or double terminator template (D) (as in Figure 3) using P235H Rho. Rates of ATP hydrolysis
by WT Rho are indicated by solid/dotted lines in (C) and (D). The rate values are stated in the panels.
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single-stranded G residues. Owing to the presence of two
hairpins in the nutR site (Figure 5D), only two G residues
of the spacer and one from the boxB were sensitive to T1
(Figure 5C).
Protection from RNase H cleavage was observed in the
spacer (oligo II-mediated) and boxB (oligo III-mediated;
Figure 5B) regions when the EC was modified with N+
NusA/NusG. There was no protection in boxA and the
region downstream of boxB (Supplementary Figure S5).
Addition of Rho to this N-modified EC did not change
the protection pattern. Consistent with our earlier
observations (23), Rho on its own produced significant
protection of the spacer region (Rho only lanes in
Figure 5B).
Similar to the RNAse H cleavage pattern, the two Gs of
the spacer region were protected by Rho from the RNAse
T1 cleavage, whereas all the three Gs (the third G is from
the boxB loop) were protected when N +NusA/NusG
were present (Figure 5C; protected part is indicated by
arrows above the intensity profile). Presence of Rho did
not change this protection pattern. Protection of spacer
and boxB by NusA and N is consistent with the fact
Figure 5. Co-occupancy of Rho and N together at the nutR/tR1 site of the nascent RNA. (A) Cartoon showing the design of a RB complex at the
H-19B nutR/tR1 terminator sequence. Nascent RNA emerging out of this stalled EC was foot-printed using RNase H and RNase T1 under different
conditions. The nascent RNA was effectively labelled only at the 50-end by selectively incorporating [aP32]CTP in the EC23 and chasing it to the lac
operator site with excess cold NTPs. The distance from boxB to lacO site is indicated. (B) RNase H and (C) RNase T1 footprinting of the nascent
RNA of the stalled EC (RB) under different conditions as indicated above the auto-radiograms. The locations of anti-sense oligos used for RNase H
footprinting are indicated by arrows. The locations of RNase H and T1 cleaved sites on the RNA are indicated in between the two gels. Protections
on RNA by Rho, N+NusA/G or Rho+N+NusA/G are indicated by dotted boxes. The protected G residues in spacer and boxB regions are also
indicated. The band intensity profiles are shown adjacent to the autoradiograms. Colour coding of the curves obtained from RNAse H and T1
cleavges are as follows: black, no factor; red, only Rho; blue, N+NusA/G; green, N, NusA/G, Rho. Protected area on these profiles are indicated
either by dotted boxes (for RNAse H) or by arrows (for T1). (D) Protection of the spacer and boxB regions by NusA, Rho and N is indicated by a
shaded box. The locations of anti-sense oligos used for RNase H footprinting are indicated by dotted arrows above the sequence. Hairpin structures
are shown by solid arrows beneath the sequence. (E) Auto-radiograms of radio-labelled NusA on a non-reducing SDS-PAGE. Cross-linking
reactions were performed in the presence of either unlabelled (WT) or SPDP labelled WT Rho (SPDP-WT) or SPDP-labelled Y80C Rho on the
elongation complex (left panel; on the same stalled EC described in A). In the right panel (F), same experiments were performed by omitting RNAP
from the reaction mix. The two cross-linked species are indicated, and their compositions were identified according to their molecular weights. The
lane for molecular weight markers was stained with coomassie blue. Bands corresponding to the ‘*’ were non-specific in nature.
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that NusA binds to spacer and N to the tetra-loop of the
boxB (12,14). Rho and NusA bind to the same spacer
region. The similar footprinting pattern of the N-Nus
complex both in the absence and presence of Rho
suggests that either Rho was not associated to the same
site or it co-occupies the site with N-Nus complex without
changing the nature of the protection. However, delay in
the rate of Rho-induced RNA release (Figure 3) or ATP
hydrolysis (Figure 4) from the N/NusA-modified stalled
EC may favour the proposal of co-occupancy of Rho with
the N-NusA complex at or near the nut/rut site.
To establish the co-occupancy of N, NusA and Rho
at the nut site more convincingly, we monitored
the cross-linking efficiency of Rho and NusA at the
nutR/rut site of the nascent RNA of the RB complex
(as in Figure 5A). We have probed NusA-Rho
cross-linking because both of them have overlapping
binding sites at the spacer region and therefore, if they
co-occupy the nutR/rut site, chances of cross-linking
between them will be higher. Also stable binding of
NusA to the spacer requires presence of N at the boxB
hairpin. Hence, NusA-Rho cross-linking effectively
provides the evidence for the N-NusA-Rho co-occupancy.
We have used a bi-functional cross-linker LC-SPDP (with
a linker length of 15 A˚; Supplementary Figure S6), which
specifically forms inter-molecular cross-links between
primary amines (e.g. lysines) of a cysteine-less protein,
C202A Rho (the only cysteine of Rho is changed to an
alanine; 22) and the cysteine side-chains of NusA (having
three cysteines). The amine-cysteine Rho-NusA
cross-linked product can be identified on a non-reducing
SDS-PAGE using radiolabelled NusA and by comparing
with appropriate molecular weight markers.
For the cross-linking experiments, similar RB
complexes as described in Figure 5A were formed in the
presence of N and NusA. SPDP-labelled WT or Y80C
Rho was added to the N-NusA modified RBs in the
presence of 1mM AMPPNP. We observed two cross-
linked products, Rho-NusA (monomers of both NusA
and Rho) and 2Rho-NusA (2 Rho sub-units and
monomer of NusA) (Figure 5E, left panel), only in the
presence of SPDP-labelled WT Rho. 2Rho-NusA species
might have formed by cross-linking of two SPDB mol-
ecules from two subunits of Rho and two cys residues of
the same NusA molecule. These products were not seen
either in the presence of unlabelled WT Rho or
SPDP-labelled Y80C Rho (21). Latter is an RNA-
binding defective mutant of Rho and never showed any
association with the EC (23). These products were also not
observed in the absence of transcription EC (Figure 5F,
right panel). We concluded that Rho can specifically be
cross-linked to NusA present in the N-NusA complex
bound to the nut/rut site of the EC, which is stalled
90 nt downstream of the boxB hairpin. This result
strongly supports the proposal of co-occupancy of
Rho-N-NusA and the possibility of Rho-NusA inter-
action at the nut/rut site.
We further measured the co-occupancy of Rho with
N-NusA at the nut/rut site by using a direct binding
assay of the former to the RB described in Figure 5A.
We added a radio-labelled WT Rho to the stalled EC
formed on an immobilized DNA template. Fraction of
Rho obtained in the pellet fraction was the measure of
association with the EC (Supplementary Figure S7A;
23). Presence of N and Nus factors with the stalled EC
did not show any effect either on the amount of
Rho-binding or on its binding kinetics (Supplementary
Figure S7B). This association of Rho was through the
nut/rut site of the nascent RNA because a Rho mutant,
Y80C (21), defective for RNA binding, did not show any
association to EC (Supplementary Figure S7C; 23). These
results further support the proposal for N-NusA-Rho
co-occupancy at the nut/rut site.
Finally, we probed the functional consequences of
the co-occupancy of N and Rho on the nutR/rut site
(Supplementary Figure S7D). We used the template
described in Figure 5A. On this template, we can measure
the Rho-dependent termination of the stalled EC at the lac
operator site and the anti-termination activity of N at the
hairpin-dependent terminator tR’. We, at first, made stalled
ECs in the presence of lac repressor (Supplementary
Figure S7D; RB, lanes 1 and 8), and they were capable of
elongation when IPTG (isopropyl b-D-1-thiogalacto-
pyranoside) was added in the absence of Rho [lanes 2
and 9, tR’ and run-off (RO) products]. The N-modified
stalled ECwas also observed to read through the tR’ termin-
ator efficiently to yield the RO product (lane 9). In the
absence of N, Rho terminated the stalled EC, which was
evident from the accumulation of the RB product over
time (lanes 3 to 7; Supplementary Figure S7E for the plot).
In the presence ofN, not only anti-terminatedproducts (RO)
were formed but also a slow accumulation of RB at the lac
operator site was observed (lanes 10 to 14; compare the N
and+N plots in Supplementary Figure S7E). These results
suggested that Rho can still terminate in the presence of
N albeit with a slower rate, which further confirmed the
co-occupancy of N, NusA/G and Rho factors at the nutR/
rut site.
Suppressor mutations in Rho
To identify whether any other steps in Rho-dependent
termination is affected by N, we looked for suppressor
mutations in Rho, which enable it to overcome N. We
randomly mutagenized the rho gene and screened for
mutants, which retained the termination function even in
the presence of WT N (see Supplementary Methods). We
isolated a Rho mutant, E134K. Another Rho mutant,
P103L, was reported to prevent growth of a certain 
phage, r32, probably by overcoming the N function
(28,35,36). We measured the anti-termination efficiency
of N at the nutR/tR1-trpt’ double terminator construct
fused to the lac-ZYA reporter, in the presence of E134K
Rho in a similar way as performed in Table 1 (see
Materials and Methods). The anti-termination efficiency
of N reduced significantly in the presence of this Rho
mutant (Figure 6A; compare %RT values). It was also
defective in supporting the growth of both the H-19B
and  phages (Supplementary Figure S8).
Next, we tested the in vitro anti-termination activities of
H-19 B N in the presence of the E134K Rho using the
H-19B nutR/tR1 terminator template (Figure 6B).
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Amount of RO product, the measure of in vitro anti-ter-
mination by N, was reduced by 5-fold compared with WT
when E134K was present (compare the %RT values
shown at the bottom of Figure 6B). Also E134K
induced early termination.
We then tested whether E134K Rho can overcome
N-mediated delay in RNA release from a stalled EC. We
first formed a stalled EC modified with N and NusA
(similar to that in Figure 3A). Interestingly, unlike its
effect on WT Rho, WT N was unable to prevent RNA
release by E134K even from the stalled EC (Figure 6C and
D; compare the release kinetics with WT Rho).
Above results strongly indicated that E134K Rho func-
tions as a suppressor of the N.
Unusual dependence of E134K Rho on NusA
Next, we explored the mechanism of suppression of N
function by E134K Rho. We hypothesized that E134K
Rho might have gained unusual transcription termination
properties, which helped it to overcome the anti-termin-
ation by N. The slow rate of RNA release by E134K Rho
from a stalled EC (Figure 6D) suggests that it may have
termination defect, and its early termination behaviour in
the presence of NusA/NusG (Figure 6B) indicates its de-
pendence on these factors. Hence, we probed the termin-
ation properties of this Rho mutant in more details.
At first, we measured the in vivo termination efficiency
of E134K Rho using the single and double terminator
cassettes (same as in Table 1), and observed severe termin-
ation defects, especially on the single-terminator construct
(Supplementary Table S2). Next, we investigated the
in vitro termination efficiency of E134K Rho both in the
presence and absence of NusA and NusG. We used two
separate templates, nutR/tR1 or trpt’ terminators fused to
the T7A1 promoter (Figure 7A and B). In case of WT
Rho, presence of NusA delays the termination window,
whereas NusG induces early termination and an inter-
mediate effect is observed in the presence of both these
factors (lanes 2–5 of 7A and 15–18 of 7B; 37). In the
Figure 6. Suppression of N by Rho mutants. (A) In vivo anti-termination activity of H-19B N in presence of WT and Rho mutants. H-19B nutR/
tR1-trpt’ terminator fused to a LacZYA reporter was used for this purpose. The average bgalactosidase activities are indicated above the bars. The
calculations of anti-termination activity (%RT) and the assays were performed in a similar way as described in Table 1. (B) Autoradiogram showing
the in vitro transcription assays at H-19B nutR/tR1 terminator under indicated conditions. Termination zones in presence of WT and mutant Rho are
indicated by two headed arrows and also with dotted lines. Size markers are indicated. Template used for the assay is shown above the gel. Amounts
of RO transcript in each lane are indicated below the gel. The concentrations of Rho (WT / mutant) and H-19B N were 50 nM and 25 nM,
respectively. The assays were done at 25 mM NTPs and in the presence of 200 nM NusG and 300 nM NusA. (C) Autoradiogram showing the amount
of RNA released by E134K Rho, both in the absence or presence of WT H-19B N from the stalled EC formed on the T7A1-nutR/tR1-lacO template
similar to that described in Figure 3A. Concentrations of E134K Rho and H-19B N were 50 nM and 100 nM, respectively. ‘S’ denotes half of the
supernatant, and ‘P’ denotes the rest of the sample. RNA release was estimated as, [2S]/([S]+[P]) and plotted against time (D) both in the absence or
presence of WT H-19B N. RNA release by WT Rho on the same template (taken from Figure 2A) is indicated by solid and dashed curves only. In
all, 300 nM NusA and 200 nM nusG were present in all the cases.
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absence of any factor, E134K Rho showed termination
defect on both the terminators (increase in the amount
of RO; lane 6 of 7A and lane 11 of 7B). Unlike WT
Rho, NusG on its own was unable to induce early termin-
ation or improve the efficiency of E134K Rho (lane 8 of
7A and lane 13 of 7B). Interestingly, instead of delaying
the termination, NusA improved the termination
efficiency and together with NusG, made E134K Rho ex-
tremely efficient and early terminating (lane 7 and 9 of 7A;
lanes 12 and 14 of 7B).
It is possible that E134K does not bind to NusG and
has acquired an unusual property of NusA-binding; there-
fore, we tested the binding of E134K Rho to NusA and
NusG by pull-down assays. We did not observe any
Figure 7. NusA-dependence of E134K Rho. Autoradiograms showing the steady state single round in vitro transcription termination in the presence
of WT and E134K Rho on H-19B nutR/tR1 terminator (A) and on trpt’ terminator template (B). Termination region is indicated by dotted lines next
to the transcript bands. RO denotes the RO product. The concentration of Rho, NusA and NusG were 50 nM, 300 nM and 200 nM, respectively. The
assay was carried out at 25 mM NTPs. (C) Autoradiogram of a native PAGE showing the migrations of the free and Rho-bound rC25 oligo and
H-19B cro RNA. rC25 is a 25 mer poly(C) RNA, and H-19B cro RNA contains the tR1 terminator sequence from the lambdoid phage H-19B. Free
and bound fractions of the RNA are indicated. Binding events were performed in the presence of ATP analogue, AMPPNP. In all the experiments,
RNAs were labelled with P32. The concentration of Rho is indicated. Concentration of labelled oligo was 10 nM. (D) ATPase assay of Rho in the
presence of poly(C) as RNA cofactor. Representative plots showing the amounts of [g-32P]ATP hydrolysed with time. The data were fitted by linear
regressions using SIGMAPLOT. Rates of ATP hydrolysis are indicated as nmol/min/mg of Rho. Fractions of RNA released by E134K (E) and WT
Rho (F) are plotted against time both in the absence or presence of NusA from the stalled EC inside H-19B nutR/tR1 termination region. The DNA
template was same as in Figure 3A.
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E134K–NusA interaction or defect in E134K–NusG
complex formation (Supplementary Figure S9A and B).
NusG–Rho interaction stimulates the termination
process by increasing the speed of RNA release and
does not affect either RNA-binding or RNA-dependent
ATPase activities of Rho (21). It is possible that E134K
may have defect in these early steps of termination, and
NusA helps to overcome these defects by a direct inter-
action at the nutR/rut site (Figure 5E).
Therefore, we, at first, tested the RNA-binding and
RNA-activated ATPase activity of E134K Rho. We
assessed the RNA binding of E134K by gel-shift assays,
using a short RNA, rC25, and a natural RNA from H-19B
phage having the nut/rut site (38). Compared with the WT
Rho, E134K mutant showed similar affinity for the
shorter RNA, but significantly weaker RNA binding (ap-
pearance of a smear is an evidence for weaker association)
for the longer RNA, which passes through the secondary
RNA binding sites (H-19B RNA; Figure 7C). It also
demonstrated slower rate of ATP hydrolysis even with
the strong Rho-substrate polyC (Figure 7D). These
results suggest that E134K Rho is defective in secondary
RNA binding, which is consistent with its location near
the path of the RNA in the central hole of the Rho struc-
ture (Supplementary Figure S10).
The defects described earlier may give rise to a slow rate
of RNA release by E134K from a stalled EC, and NusA
may improve this rate. We measured the RNA release by
E134K from a stalled EC, similar to the one described in
Figure 3A and checked the effect of NusA on it. NusA
improved the rate of RNA release of E134K significantly
(Figures 7E; compare the slopes), which was in contrast to
what was observed for WT Rho (Figure 7F). Hence,
NusA improves the termination efficiency of E134K by
increasing its rate of RNA release, and this might have
stimulated NusG function indirectly (Figure 7A and B,
lanes 9 and 18). The RNA-binding function of NusA is
observed only when it is a part of the EC. Hence, we did
not attempt to follow the effect of NusA on E134K on
either the RNA-binding or RNA-dependent ATPase
assays outside the EC.
Presence of NusA very close to Rho at the nut/rut site
(Figure 5E) can help E134K mutant to properly bind the
RNA in its secondary binding site(s) and to speed-up its
isomerization steps leading to a translocase competent
state. This could explain the unusual functional depend-
ence of this Rho mutant on NusA.
This dependence of E134K Rho on NusA might have
perturbed the N-NusA interaction at the nut site, which in
turn affected the anti-termination function of N. And this
could be the likely mechanism for the suppressor action of
E134K.
DISCUSSION
A multi-pronged strategy of N to overcome Rho
The small anti-terminator protein N has three interacting
regions (Supplementary Figure S1A). They interact with
the nut site on mRNA (12), with the nut-bound NusA (13)
and with the RNAP (13). Here, we show that N uses all
these three interaction modules to use a multi-pronged
strategy to overcome the Rho action.
(i) N-NusA-Rho forms a ternary complex at the nut/
rut site (Figure 5), and this configuration inactivates
Rho (Figure 4), which in turn slows down the trans-
location and the RNA release kinetics of Rho
(Figure 3). Most likely, the presence of N and
NusA at the nut site affects the proper placement
of the downstream RNA into the central hole of the
Rho hexamer (mechanism 1 in Figure 1A). This in-
hibition of Rho function at the nut site does not
require N induced modification of the EC (Table 1).
(ii) N-CTD interacts with RNAP near the RNA exit
channel and may use this channel to penetrate a
part of its ‘thread-like’ CTD into the interior of
the EC (16,17). This interaction becomes important
to prevent Rho action when the EC moves away
from the nut site allowing Rho to freely bind and
translocate along the nascent RNA present between
the nut site and the EC (Table 1, Figure 1B).
Although it has not been proved, the RNA exit
channel could be the likely area through which
Rho gains access to the RNAP. Presence of
N-CTD and NusA-NTD (11) in the vicinity of the
exit channel may function as a lid to the Rho-access
point and prevent/delay the putative Rho-RNAP
interaction (mechanism II, Figure 1B).
(iii) The unusual dependence of the E134K Rho on
NusA for efficient termination (Figure 7) and its
suppression activity of N function (Figure 6) led
us to propose that Rho and N compete for the
same NusA molecule bound to the nut site.
N-NusA interaction removes NusA from the Rho-
dependent termination pathway and makes the
latter process less efficient on the tR1-like termin-
ators (mechanism III, Figure 1C).
(iv) NusG stimulatesNactivity in vitro (29) andwas shown
to be a part of the in vivo anti-termination process (39).
On the other hand, Rho interacts with the C-terminal
domain of NusG (22,40), and this interaction is es-
sential for an efficient termination. We observed
that in vivo, NusG-CTD mutants defective for Rho
binding (22) did not have any effect on N function
(Supplementary Table S3). Hence, we concluded that
N functions independent of Rho-NusG CTD inter-
action. However, incorporation of NusG into the
N-anti-termination machinery can alter NusG-NTD-
b’ clamp helices interactions, which in turn may
perturb the Rho-NusG complex formation.
NusA-remodelling, as a possible anti-termination
mechanism of the anti-terminator, N
NusA interacts with RNAP and also with the nascent
RNA emerging out of the EC (41,42). It is an important
component for both the termination and the anti-termin-
ation processes. NusA improves the efficiency of hairpin-
dependent termination likely by stabilizing the RNA
hairpins of the terminators (42,43,44). It is also involved
in Rho-dependent termination (37,42,45). On the other
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hand, anti-terminators like N- and Q-functions are highly
NusA-dependent (11,42). N makes NusA more specific to
nut site (14) and also changes its mode of interaction with
RNAP (19), whereas in the presence of Q protein, NusA
forms a shield at the RNA exit channel (46). Specific inter-
action of N with NusA leads to a ‘NusA-remodelling’, and
its subsequent removal from the termination pathway may
be by following means.
(i) As Rho and NusA binding sites (‘spacer’ region;
also Figure 5) at the nutR/rut overlap, the high
affinity N-NusA interaction at the nut site may
make NusA unavailable to Rho during its loading
to and activation by the nut RNA.
(ii) NusA-b-flap interaction near the RNA exit channel
(11) could be instrumental in helping Rho to access
the interior of the EC. The proposed N-induced (19)
changes in the NusA-RNAP interaction is likely to
affect the putative Rho-RNAP interaction or the
terminator hairpin folding at the RNA exit channel.
We propose that ‘NusA-remodelling’ could be an
important mechanism used by N to overcome both the
Rho-dependent and -independent terminations in
addition to stabilizing the transcription ECs.
What is the role of NusA in the Rho-dependent
termination?
Involvement of NusA in Rho-dependent termination has
been implicated in different reports (37,45,47,48). The role
of NusA in this process is still unknown. Here, for the first
time, we report a Rho mutant, E134K, whose function is
highly dependent on NusA and not on NusG (Figure 7).
NusA improves the termination efficiency of E134K by
increasing the rate of RNA release and stimulating the
NusG function. We suggest that the secondary RNA
binding defect of E134K (Figure 7C and D) is rectified
by NusA-mediated chaperoning of the RNA into the sec-
ondary channel, and this stabilization of RNA in the
central hole may also stimulate the NusG function.
Based on these results, we propose that the role of
NusA is important for a subset of Rho-dependent termin-
ators, where Rho-loading onto the RNA and subsequent
activation step(s) are rate limiting. In these terminators,
owing to the structural constraints, the nascent RNA
cannot be placed properly into the central hole of the
hexameric Rho, thereby affecting its ‘open’ to ‘close’
isomerization step(s) and the rate of initiation of ATP
hydrolysis. Analogous to the chaperoning role of NusA
for the Rho-independent terminators with imperfect RNA
hairpins, we envisioned that it also functions as a
RNA-chaperone to guide the nascent RNA into the
central hole of the hexameric Rho.
Spatial relationship among N, NusA, NusG and Rho on
the RNAP
Aforementioned discussion indicates a spatial relationship
among the factors of the termination and anti-termination
machinery on the EC, which probably enables both N and
Rho to compete for the same NusA and NusG molecules
bound to the RNAP surface and use them as vehicles to
access the interior of RNAP. On interacting with these
two factors, Rho and N are likely to alter the conform-
ations of the b-flap domain near the RNA exit channel
and the b’-clamp helices near the non-template strand at
the active centre. Rho-NusG CTD interaction not only
helps Rho to be recruited to the EC but may also alter
the NusG-NTD -b’ clamp helices interactions. On the
other hand, N is likely to change conformations in the
RNA exit channel by directly interacting with NusA and
bringing about alterations in the flap-domain. Therefore,
it is likely that these two structural elements of RNAP on
their own and cross-talk between them play pivotal roles
in both termination and anti-termination processes.
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